نتائج البحث - "Julian Walter Holch"

1

Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) study

المؤلفون: Jobst C. von Einem, Volker Heinemann, Kathrin Heinrich, Swantje Held, Dominik Paul Modest, Andreas Jung, Sebastian Stintzing, Alessia Fraccaroli, Werner Scheithauer, Michael Haas, Frank Kullmann, Ludwig Fischer von Weikersthal, Markus Moehler, Julian Walter Holch, Christoph Schulz

المصدر: Anti-cancer drugs. 31(8)

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, medicine.medical_specialty, Renal Tubular Transport, Inborn Errors, Bevacizumab, Side effect, Colorectal cancer, Hypercalciuria, Leucovorin, Cetuximab, Irinotecan, Gastroenterology, Hypomagnesemia, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Pharmacology (medical), Magnesium, Aged, Retrospective Studies, Pharmacology, business.industry, Hazard ratio, medicine.disease, Prognosis, Survival Rate, Nephrocalcinosis, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, FOLFIRI, Camptothecin, Female, Fluorouracil, business, Colorectal Neoplasms, medicine.drug, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::803dd08f49abea75d998cea6425575edTest
https://pubmed.ncbi.nlm.nih.gov/32639280Test

2

Impact of Size and Location of Metastases on Early Tumor Shrinkage and Depth of Response in Patients With Metastatic Colorectal Cancer: Subgroup Findings of the Randomized, Open-Label Phase 3 Trial FIRE-3/AIO KRK-0306

المؤلفون: Alena Britta Gesenhues, Sebastian Stintzing, Felix Hofmann, Dominik Nörenberg, Elina L. Petersen, Wieland H. Sommer, Nina Hesse, Matthias F Froelich, Dominik Paul Modest, Volker Heinemann, Julian Walter Holch

المصدر: Clinical colorectal cancer. 19(4)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63f6238dc81c5c8ffe87894478fd68edTest
https://pubmed.ncbi.nlm.nih.gov/32917529Test

3

Relevance of liver‐limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE‐3/AIO KRK0306 trial

المصدر: International Journal of Cancer. 142:1047-1055

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29874f96142ae356a9977d9860ef22a0Test
https://doi.org/10.1002/ijc.31114Test

4

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

المؤلفون: Ursula Vehling-Kaiser, Marlies Michl, Jobst C. von Einem, Andreas Jung, Thomas Kirchner, Julian Walter Holch, Andreas Schalhorn, Jens Neumann, Arndt Stahler, Sebastian Stintzing, D. Quietzsch, Stephan Kruger, Dominik Paul Modest, Alexander Crispin, Martina Stauch, Clemens Giessen-Jung, Volker Heinemann, Ludwig Fischer von Weikersthal, Michael J. Haas

المصدر: Anti-Cancer Drugs. 28:717-722

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Organoplatinum Compounds, Receptor, ErbB-3, Receptor, ErbB-2, Colorectal cancer, Neuregulin-1, Leucovorin, Irinotecan, HER2/neu, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, medicine, Humans, Pharmacology (medical), Neoplasm Metastasis, Retrospective Studies, Pharmacology, biology, business.industry, Hazard ratio, Retrospective cohort study, Prognosis, medicine.disease, Confidence interval, Oxaliplatin, Surgery, 030104 developmental biology, 030220 oncology & carcinogenesis, biology.protein, Biomarker (medicine), Camptothecin, Fluorouracil, Colorectal Neoplasms, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bafc917324cff303ee44693f9cc45e8Test
https://doi.org/10.1097/cad.0000000000000510Test

5

The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials

المؤلفون: Volker Heinemann, Ingrid Ricard, Dominik Paul Modest, Julian Walter Holch, Sebastian Stintzing

المصدر: European Journal of Cancer. 70:87-98

مصطلحات موضوعية: Vascular Endothelial Growth Factor A, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, Colorectal cancer, medicine.medical_treatment, Angiogenesis Inhibitors, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Panitumumab, Randomized Controlled Trials as Topic, Retrospective Studies, Cetuximab, business.industry, Hazard ratio, Antibodies, Monoclonal, Prognosis, medicine.disease, Survival Analysis, Surgery, ErbB Receptors, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, Meta-analysis, Colorectal Neoplasms, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da836273e08d43d7d5de259ed578d52aTest
https://doi.org/10.1016/j.ejca.2016.10.007Test

6

Efficacy of bevacizumab in first-line treatment of metastatic colorectal cancer : A systematic review and meta-analysis

المؤلفون: Alexander Baraniskin, Wolff Schmiegel, Ulli Graeven, Julian Walter Holch, Barbara Buchberger, Christian Pox, Volker Heinemann

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Time Factors, Bevacizumab, Colorectal cancer, medicine.medical_treatment, MEDLINE, Cochrane Library, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Neoplasm Metastasis, Randomized Controlled Trials as Topic, Chemotherapy, business.industry, Hazard ratio, Wirtschaftswissenschaften, medicine.disease, Progression-Free Survival, First line treatment, 030104 developmental biology, 030220 oncology & carcinogenesis, Meta-analysis, Disease Progression, Colorectal Neoplasms, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::024d48a47a2f7dfded17de8b88201712Test
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85056809277Test

7

Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)

المؤلفون: Ingrid Ricard, J. C. von Einem, Christoph Kahl, Christoph B. Westphalen, Werner Scheithauer, Marlies Michl, M. Moehler, Ursula Vehling-Kaiser, Dominik Paul Modest, Sebastian Stintzing, Tobias Heintges, Ivan Jelas, Alexander Kiani, Frank Kullmann, Volker Heinemann, L. Fischer von Weikersthal, Thomas Decker, Julian Walter Holch

المصدر: European journal of cancer (Oxford, England : 1990). 106

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, Time Factors, Colorectal cancer, Leucovorin, Cetuximab, medicine.disease_cause, Gastroenterology, 0302 clinical medicine, Carcinoembryonic antigen, Risk Factors, Antineoplastic Combined Chemotherapy Protocols, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, biology, Hazard ratio, Middle Aged, Progression-Free Survival, Up-Regulation, Bevacizumab, Oncology, 030220 oncology & carcinogenesis, FOLFIRI, Female, KRAS, Fluorouracil, Colorectal Neoplasms, medicine.drug, Adult, medicine.medical_specialty, 03 medical and health sciences, Internal medicine, medicine, Humans, neoplasms, Aged, Retrospective Studies, business.industry, Odds ratio, medicine.disease, digestive system diseases, Carcinoembryonic Antigen, 030104 developmental biology, Clinical Trials, Phase III as Topic, biology.protein, Camptothecin, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db427639897a9a8442afe5d29fcf7f1fTest
https://pubmed.ncbi.nlm.nih.gov/30496943Test

8

Prognostic value of radiologically enlarged lymph nodes in patients with metastatic colorectal cancer: Subgroup findings of the randomized, open-label FIRE-3/AIO KRK0306 trial

المؤلفون: Alena B. Baumann, Ingrid Ricard, Sebastian Stintzing, Maximilian F. Reiser, Felix Hofmann, Julian Walter Holch, Melvin D'Anastasi, Volker Heinemann, Dominik Paul Modest, Nina Hesse, Wieland H. Sommer

المصدر: European journal of radiology. 100

مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, Bevacizumab, Colorectal cancer, Colon, Population, Leucovorin, Cetuximab, Antineoplastic Agents, medicine.disease_cause, Irinotecan, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Radiology, Nuclear Medicine and imaging, Prospective Studies, education, Aged, Proportional Hazards Models, Retrospective Studies, education.field_of_study, Proportional hazards model, business.industry, Hazard ratio, General Medicine, Middle Aged, medicine.disease, Prognosis, Survival Analysis, Treatment Outcome, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Camptothecin, Female, Lymph, KRAS, Fluorouracil, Lymph Nodes, business, Colorectal Neoplasms, Tomography, X-Ray Computed, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83107934090327eb054f761f87a900ebTest
https://pubmed.ncbi.nlm.nih.gov/29496069Test

9

Evaluation of survival across several treatment lines in metastatic colorectal cancer: Analysis of the FIRE-3 trial (AIO KRK0306)

المؤلفون: Christoph B. Westphalen, Sebastian Stintzing, Christoph Kahl, L. Fischer von Weikersthal, Dominik Paul Modest, Ursula Vehling-Kaiser, Thomas Decker, Julian Walter Holch, S.-E. Al-Batran, G. Seipelt, Ingrid Ricard, J. C. von Einem, Alexander Kiani, Tobias Heintges, Volker Heinemann, M. Moehler, Swantje Held, Frank Kullmann, Werner Scheithauer

المصدر: European journal of cancer (Oxford, England : 1990). 84

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Time Factors, Bevacizumab, Leucovorin, Cetuximab, Context (language use), Angiogenesis Inhibitors, Kaplan-Meier Estimate, medicine.disease_cause, Proto-Oncogene Proteins p21(ras), 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Biomarkers, Tumor, Humans, 030212 general & internal medicine, Neoplasm Metastasis, Survival analysis, Proportional Hazards Models, Proportional hazards model, business.industry, Hazard ratio, Intention to Treat Analysis, Treatment Outcome, 030220 oncology & carcinogenesis, Mutation, FOLFIRI, Camptothecin, KRAS, Fluorouracil, business, Colorectal Neoplasms, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c026cf263089ec9d6e02a7fc7212edb1Test
https://pubmed.ncbi.nlm.nih.gov/28942867Test

10

Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial

المصدر: Journal of Cancer Research and Clinical Oncology

مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Colorectal cancer, medicine.medical_treatment, Original Article – Clinical Oncology, Cetuximab, Antibodies, Monoclonal, Humanized, medicine.disease_cause, Disease-Free Survival, Capecitabine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, CAPIRI plus cetuximab, medicine, Humans, Codon, neoplasms, Aged, Chemotherapy, business.industry, KRAS mutation status, CAPOX plus cetuximab, General Medicine, Middle Aged, Prognosis, medicine.disease, Primary tumor, digestive system diseases, Oxaliplatin, Irinotecan, ras Proteins, Female, Primary tumor location, KRAS, Colorectal Neoplasms, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f30b299988de089cee7190e361bdf494Test
https://doi.org/10.1007/s00432-014-1678-3Test

تنقيح النتائج